Results 181 to 190 of about 2,241,891 (219)

A Framework for the Estimation of Quality-Adjusted Life-Years Using Joint Models of Longitudinal and Survival Data. [PDF]

Med Decis Making
Crowther MJ, Gasparini A, Ekberg S, Felizzi F, Gallagher E, Paracha N.   +5 more
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Intrinsic capacity is associated with cardiovascular rehabilitation outcome in older adults: a multidimensional comparison with frailty. [PDF]

J Nutr Health Aging
Bencivenga L, Vassallo A, Curcio G, Zanobbi V, Ceparano LA, Komici K, Formisano R, Corbi G, Femminella GD, Maniscalco M, Papa A, Rengo G.   +11 more
europepmc   +1 more source

Serum S100B and Clinical Outcomes After Spontaneous Subarachnoid Hemorrhage: A Prospective Observational Study. [PDF]

Mol Neurobiol
Auricchio AM, Baroni S, Nichelatti M, Napoli G, Calvanese F, Ceccarelli GM, Martinelli R, Menna G, Obersnel M, Scarcia L, Alexandre A, Caricato A, Sturiale CL, Albanese A, Marchese E, Doglietto F, Urbani A, Olivi A, Pepa GMD.   +18 more
europepmc   +1 more source